Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives

Before the introduction of tyrosine kinase inhibitors (TKIs) for a particular subgroup of patients, despite platinum-based combination chemotherapy, the majority of patients affected by non-small-cell lung cancer (NSCLC) did not live longer than one year. With deeper understanding of tumor molecular...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Ferrara, Miriam Grazia, Di Noia, Vincenzo, D’Argento, Ettore, Vita, Emanuele, Damiano, Paola, Cannella, Antonella, Ribelli, Marta, Pilotto, Sara, Milella, Michele, Tortora, Giampaolo, Bria, Emilio
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7281569/
https://ncbi.nlm.nih.gov/pubmed/32397295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051196
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky